Jane Carlisle Maxwell, PhD, is an expert in monitoring changes in drug use patterns in Texas, the United States and internationally. Her research specialties include trends and patterns of substance abuse nationally and internationally, with special interest in methadone mortality; the U.S-Mexico border; patterns of use and abuse of methamphetamine, party and synthetic drugs, heroin, and prescription drugs; the relationship of substance abuse and traffic safety; and the relationship of substance abuse and HIV/AIDS and other sexually transmitted diseases.
Maxwell has been a member of SAMHSA’s National Advisory Council, a consultant to the Food and Drug Administration and Centers for Disease Control, a Fulbright Senior Specialist, a member of the National Institute on Drug Abuse’s Community Epidemiology Work Group and NIDA’s National Drug Early Warning System.
Trends and patterns of substance abuse in Texas, nationally, and internationally, with special interest on the US-Mexico border; patterns of use and abuse of methamphetamine, party drugs, methadone, and other opiate drugs; impaired driving programs; synthetic estimation techniques.
- Why Texas requires its own solutions to the opioid epidemic
- "Safe" synthetic marijuana is far from safe
- Growing use of meth in Texas
- Drinking, driving and drugs: Trajectories of DWI recidivism and how to intervene (2016)
- Epidemiology of drinking and disorders in border vs. non-border contexts (2015)
- DWI Offender Education Program (2014)
- Monitoring the changing methamphetamine market in the Austin area (2013)
- Advancing recovery: State and provider partnership for quality addiction services (2010)
- Normalization of heroin: A study of heroin as a "club drug" (2005)
- Center for Excellence in Drug Epidemiology (SAMHSA)